WallStreetZenWallStreetZen

NASDAQ: DBVT
Dbv Technologies Sa Stock Forecast, Predictions & Price Target

Analyst price target for DBVT

Based on 1 analyst offering 12 month price targets for Dbv Technologies Sa.
Min Forecast
$10.00+852.38%
Avg Forecast
$10.00+852.38%
Max Forecast
$10.00+852.38%

Should I buy or sell DBVT stock?

Based on 1 analyst offering ratings for Dbv Technologies Sa.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DBVT stock forecasts and price targets.

DBVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-08

1 of 1

Forecast return on equity

Is DBVT forecast to generate an efficient return?
Company
-17.27%
Industry
76.1%
Market
79%
DBVT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DBVT forecast to generate an efficient return on assets?
Company
-13.22%
Industry
30.96%
DBVT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DBVT earnings per share forecast

What is DBVT's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.22
Avg 2 year Forecast
-$0.94
Avg 3 year Forecast
-$0.82

DBVT revenue forecast

What is DBVT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.7M-61.79%
Avg 2 year Forecast
$6.3M-57.97%
Avg 3 year Forecast
$29.2M+95.29%
DBVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DBVT revenue growth forecast

How is DBVT forecast to perform vs Biotechnology companies and vs the US market?
Company
19.44%
Industry
35%
Market
9.85%
DBVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DBVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DBVT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DBVT$1.05$10.00+852.38%Buy
VTGN$3.69N/AN/A
ATHA$2.60$19.00+630.77%Buy
ARMP$2.86$7.00+144.76%Buy
AFMD$6.86$13.33+94.36%Buy

Dbv Technologies Sa Stock Forecast FAQ

Is Dbv Technologies Sa Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DBVT) stock is to Buy DBVT stock.

Out of 1 analyst, 0 (0%) are recommending DBVT as a Strong Buy, 1 (100%) are recommending DBVT as a Buy, 0 (0%) are recommending DBVT as a Hold, 0 (0%) are recommending DBVT as a Sell, and 0 (0%) are recommending DBVT as a Strong Sell.

If you're new to stock investing, here's how to buy Dbv Technologies Sa stock.

What is DBVT's earnings growth forecast for 2024-2026?

(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.61%.

Dbv Technologies Sa's earnings in 2024 is -$79,510,000.On average, 1 Wall Street analyst forecast DBVT's earnings for 2024 to be -$117,649,930, with the lowest DBVT earnings forecast at -$117,649,930, and the highest DBVT earnings forecast at -$117,649,930. On average, 1 Wall Street analyst forecast DBVT's earnings for 2025 to be -$90,648,307, with the lowest DBVT earnings forecast at -$90,648,307, and the highest DBVT earnings forecast at -$90,648,307.

In 2026, DBVT is forecast to generate -$79,076,183 in earnings, with the lowest earnings forecast at -$79,076,183 and the highest earnings forecast at -$79,076,183.

What is DBVT's revenue growth forecast for 2024-2026?

(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 19.44% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Dbv Technologies Sa's revenue in 2024 is $14,942,000.On average, 1 Wall Street analysts forecast DBVT's revenue for 2024 to be $550,640,247, with the lowest DBVT revenue forecast at $550,640,247, and the highest DBVT revenue forecast at $550,640,247. On average, 1 Wall Street analysts forecast DBVT's revenue for 2025 to be $605,607,837, with the lowest DBVT revenue forecast at $605,607,837, and the highest DBVT revenue forecast at $605,607,837.

In 2026, DBVT is forecast to generate $2,813,954,887 in revenue, with the lowest revenue forecast at $2,813,954,887 and the highest revenue forecast at $2,813,954,887.

What is DBVT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DBVT) forecast ROA is -13.22%, which is lower than the forecast US Biotechnology industry average of 30.96%.

What is DBVT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DBVT price target, the average DBVT price target is $10.00, with the highest DBVT stock price forecast at $10.00 and the lowest DBVT stock price forecast at $10.00.

The Wall Street analyst predicted that Dbv Technologies Sa's share price could reach $10.00 by May 8, 2025. The average Dbv Technologies Sa stock price prediction forecasts a potential upside of 852.38% from the current DBVT share price of $1.05.

What is DBVT's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: DBVT) Dbv Technologies Sa's current Earnings Per Share (EPS) is -$0.82. On average, analysts forecast that DBVT's EPS will be -$1.22 for 2024, with the lowest EPS forecast at -$1.22, and the highest EPS forecast at -$1.22. On average, analysts forecast that DBVT's EPS will be -$0.94 for 2025, with the lowest EPS forecast at -$0.94, and the highest EPS forecast at -$0.94. In 2026, DBVT's EPS is forecast to hit -$0.82 (min: -$0.82, max: -$0.82).

What is DBVT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DBVT) forecast ROE is -17.27%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.